With 3 mL bacteriostatic water
30.0 units
Page last checked
Reconstitution · NAD+
Pick the vial, the water you added and the dose. Get the exact draw in units for the syringe in your hand.
Step 1 of 4
This vial holds 500 mg in total.
U-100 insulin syringe · 1 mL · lines every 2 units · 1 unit = 0.01 mL
50.0 units on a U-100 insulin syringe · 1 mL · lines every 2 units, which is 0.50 milliliters. The draw lands on a syringe line.
Your address is used to send this one card. The email also includes an optional link for updates when our data changes. Nothing else is sent unless you choose that link, and you can unsubscribe anytime.
NAD+ is a substance every cell uses to turn food into energy and carry out repair work. It is a coenzyme, not a peptide. Clinics promote NAD+ IV drips and injections for energy, focus, recovery, hangovers, addiction recovery and healthy aging.
The human studies on NAD+ itself are small and used IV infusions. They have not shown that NAD+ injections improve those goals. The clearest finding so far is discomfort during the drip, including stomach symptoms, a faster heartbeat and chest pressure.
Each row uses 500 mg and the liquid volume shown. Dividing the amount by that volume gives the calculated concentration. The rows are arithmetic examples, not alternative product preparations.
With 3 mL bacteriostatic water
30.0 units
With 5 mL bacteriostatic water
50.0 units
| Bacteriostatic water | Concentration | Per U-100 unit | Draw for 50 mg | Nearest syringe line |
|---|---|---|---|---|
| 3 mL | 166.67 mg/mL | 1,666.7 mcg | 30.0 u · 0.300 mL | exactly 30 u |
| 5 mL | 100.00 mg/mL | 1,000.0 mcg | 50.0 u · 0.500 mL | exactly 50 u |
The amount, liquid volume and dose shown here are the calculator’s starting example for NAD+. Replace them with your own values. Every result in the table is calculated from those inputs.
The NAD+ preset uses a large vial amount. The calculator still follows the same relationship: amount divided by modeled liquid volume gives concentration. It does not measure the preparation or determine its final volume.
The worked calculation uses the entered water volume as the solution volume. That is a modeling assumption. The tool cannot measure any difference between liquid added and final prepared volume, or determine a correction from the powder’s appearance.
There is no measured displacement adjustment in this calculation. Where a preparation has a stated final concentration, that concentration is information about the actual preparation; a preset is only an example. A mismatch between them needs clarification rather than an invented correction.
The NAD+ record uses amounts expressed in milligrams. A decimal or unit error changes the amount represented by a draw even when the displayed syringe reading looks familiar. The vial total is also different from the amount requested for one draw.
Read the conversion table’s amount and volume together. Syringe units are a way to read a particular scale, not a universal NAD+ dose. A remembered unit count loses its meaning when the concentration or syringe changes.
The guide includes registered intravenous study protocols. Registration records describe a plan and its status; they do not, on their own, establish completed results or a regimen for use under the skin.
The calculator does not translate an infusion protocol into an injection schedule. Its output describes the current inputs only. Evidence about route, preparation and outcomes needs to be read in the study context, separately from whether the liquid-volume arithmetic is correct.
The cited registered studies investigate different populations, amounts and treatment periods. A registered protocol records a plan; it is not, by itself, a published result or proof of a benefit from an infusion.
Nicotinamide riboside and nicotinamide mononucleotide are different molecules that the body can use to make NAD+. A study of either one does not automatically give a dose for direct NAD+ use. The exact substance and route still matter.
An infusion protocol includes more than the mass of NAD+. It also describes the liquid used, the delivery time and the checks made during treatment. A result in syringe units cannot stand in for that full plan.
Vial strength is the amount available for the math. It does not tell you how much benefit to expect or which amount suits a person. Each trial’s dose remains attached to the question that study is asking.
Nicotinamide riboside and nicotinamide mononucleotide are different molecules that the body can use to make NAD+. A study of either one does not automatically give a dose for direct NAD+ use. The exact substance and route still matter.
An infusion protocol includes more than the mass of NAD+. It also describes the liquid used, the delivery time and the checks made during treatment. A result in syringe units cannot stand in for that full plan.
Vial strength is the amount available for the math. It does not tell you how much benefit to expect or which amount suits a person. Each trial’s dose remains attached to the question that study is asking.
Mix 500 mg into 5 mL and one U-100 unit carries 1,000.0 mcg. The table shows how much peptide is in each numbered syringe line. These are conversion examples, not suggested doses.
| U-100 line | Volume | Mass (mcg) | Mass (mg) |
|---|---|---|---|
| 10 u | 0.10 mL | 10,000 mcg | 10 mg |
| 20 u | 0.20 mL | 20,000 mcg | 20 mg |
| 30 u | 0.30 mL | 30,000 mcg | 30 mg |
| 40 u | 0.40 mL | 40,000 mcg | 40 mg |
| 50 u | 0.50 mL | 50,000 mcg | 50 mg |
| 60 u | 0.60 mL | 60,000 mcg | 60 mg |
| 70 u | 0.70 mL | 70,000 mcg | 70 mg |
| 80 u | 0.80 mL | 80,000 mcg | 80 mg |
| 90 u | 0.90 mL | 90,000 mcg | 90 mg |
| 100 u | 1.00 mL | 100,000 mcg | 100 mg |
The math is only one part of the question. These guides cover the compound, published doses, side effects, mixing steps and supplies.